Literature DB >> 12117918

Novel 33-kilodalton lipoprotein from Mycobacterium leprae.

Yumi Maeda1, Masahiko Makino, Dean C Crick, Sebabrata Mahapatra, Sopa Srisungnam, Takemasa Takii, Yoshiko Kashiwabara, Patrick J Brennan.   

Abstract

A novel Mycobacterium leprae lipoprotein LpK (accession no. ML0603) was identified from the genomic database. The 1,116-bp open reading frame encodes a 371-amino-acid precursor protein with an N-terminal signal sequence and a consensus motif for lipid conjugation. Expression of the protein, LpK, in Escherichia coli revealed a 33-kDa protein, and metabolic labeling experiments and globomycin treatment proved that the protein was lipidated. Fractionation of M. leprae demonstrated that this lipoprotein was a membrane protein of M. leprae. The purified lipoprotein was found to induce production of interleukin-12 in human peripheral blood monocytes. The studies imply that M. leprae LpK is involved in protective immunity against leprosy and may be a candidate for vaccine design.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117918      PMCID: PMC128180          DOI: 10.1128/IAI.70.8.4106-4111.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Leprosy. Global situation.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2002-01-04

2.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Authors:  S A Fulton; J M Johnsen; S F Wolf; D S Sieburth; W H Boom
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  IL12 and the human immune response to mycobacteria.

Authors:  R L Modlin; P F Barnes
Journal:  Res Immunol       Date:  1995 Sep-Oct

4.  Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent.

Authors:  K L Franken; H S Hiemstra; K E van Meijgaarden; Y Subronto; J den Hartigh; T H Ottenhoff; J W Drijfhout
Journal:  Protein Expr Purif       Date:  2000-02       Impact factor: 1.650

5.  Massive gene decay in the leprosy bacillus.

Authors:  S T Cole; K Eiglmeier; J Parkhill; K D James; N R Thomson; P R Wheeler; N Honoré; T Garnier; C Churcher; D Harris; K Mungall; D Basham; D Brown; T Chillingworth; R Connor; R M Davies; K Devlin; S Duthoy; T Feltwell; A Fraser; N Hamlin; S Holroyd; T Hornsby; K Jagels; C Lacroix; J Maclean; S Moule; L Murphy; K Oliver; M A Quail; M A Rajandream; K M Rutherford; S Rutter; K Seeger; S Simon; M Simmonds; J Skelton; R Squares; S Squares; K Stevens; K Taylor; S Whitehead; J R Woodward; B G Barrell
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.

Authors:  V Ng; G Zanazzi; R Timpl; J F Talts; J L Salzer; P J Brennan; A Rambukkana
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

8.  Multidrug resistant Mycobacterium leprae from patients with leprosy.

Authors:  S Maeda; M Matsuoka; N Nakata; M Kai; Y Maeda; K Hashimoto; H Kimura; K Kobayashi; Y Kashiwabara
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Production of the 19-kDa antigen of Mycobacterium tuberculosis in Escherichia coli and its purification.

Authors:  R L Prestidge; P M Grandison; D W Chuk; R J Booth; J D Watson
Journal:  Gene       Date:  1995-10-16       Impact factor: 3.688

10.  Accumulation of glyceride-containing precursor of the outer membrane lipoprotein in the cytoplasmic membrane of Escherichia coli treated with globomycin.

Authors:  M Hussain; S Ichihara; S Mizushima
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

View more
  4 in total

1.  Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei.

Authors:  Linnell B Randall; Karen Dobos; Krisztina M Papp-Wallace; Robert A Bonomo; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.

Authors:  Stéphanie Matrat; Stéphanie Petrella; Emmanuelle Cambau; Wladimir Sougakoff; Vincent Jarlier; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

3.  A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins.

Authors:  M Madan Babu; M Leena Priya; A Tamil Selvan; Martin Madera; Julian Gough; L Aravind; K Sankaran
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

4.  A lipopeptide facilitate induction of Mycobacterium leprae killing in host cells.

Authors:  Yumi Maeda; Toshiki Tamura; Yasuo Fukutomi; Tetsu Mukai; Masanori Kai; Masahiko Makino
Journal:  PLoS Negl Trop Dis       Date:  2011-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.